Tilray(TLRY)
Search documents
Why I Wouldn't Touch Tilray Brands Stock With a 10-Foot Pole
Yahoo Finance· 2026-03-18 13:35
Is Tilray Brands (NASDAQ: TLRY) finally bouncing back? After years of poor performance, the stock has climbed 7% over the past 12 months, which isn't bad by its standards. What's more, the market cheered the company's latest financial results. And with regulatory progress in the U.S. cannabis market, some see a bright future ahead for the pot grower. However, Tilray Brands still isn't worth investing in, not even close, in my view. Here's why I'd advise anyone to stay far away. Image source: Getty Images. ...
Breckenridge Distillery Expands Its Colorado Presence with Cheba Hut Partnership
Globenewswire· 2026-03-18 11:00
BRECKENRIDGE, Colo., March 18, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY is excited to announce that Cheba Hut 'Toasted' Subs will roll out Breckenridge Distillery products across 18 Colorado-based Cheba Hut restaurants. This will bring Breckenridge Distillery’s award-winning Bourbon Whiskey to all participating locations, with select restaurants in Boulder, Dillon, and one Denver location also pouri ...
Will Tilray Brands' Diversification Strategy Pay Off for Investors?
Yahoo Finance· 2026-03-16 14:50
Expanding into new segments can present a business and its investors with more plentiful growth opportunities. It can also be an effective way to be less dependent on a particular market or industry. For years, Tilray Brands (NASDAQ: TLRY) and other Canadian-based cannabis companies have been hopeful that the U.S. might soon legalize marijuana, which would open up a massive market for them. That hasn't happened, and it has resulted in some cannabis companies disappearing, becoming leaner, or, in Tilray's ...
Tilray Brands Enters Agreement to Acquire BrewDog’s Key U.S. Assets, Expanding Its U.S. Craft Beer Platform
Globenewswire· 2026-03-16 11:00
NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis, and wellness industries, today announced that the Company has entered into an asset purchase agreement to acquire certain strategic assets of BrewDog in the United States, including its brewery, pub, and hotel in Columbus, Ohio, as well as the pubs in New Albany, Ohio, Cl ...
Tilray Expands German Healthcare Push With Strategic Pharma Deal - Tilray Brands (NASDAQ:TLRY)
Benzinga· 2026-03-12 15:37
Core Viewpoint - Tilray Brands is entering a strategic partnership with pharmaceutical entities in Germany to enhance its market presence and improve access to its products [1][7]. Group 1: Strategic Partnership - The partnership involves collaboration with Tilray Medical, CC Pharma, and 14U Pharma, aimed at expanding product offerings and pharmacy access [1][2]. - Effective April 1, 2026, the alliance will leverage CC Pharma's distribution network, which supports over 16,000 pharmacies in Germany [2]. Group 2: Market Position and Performance - The collaboration is expected to strengthen Tilray's position in the dynamic German healthcare market [3]. - Despite a slight downturn in the broader market, Tilray's stock is underperforming, indicating company-specific challenges [3][7]. Group 3: Recent Developments - Tilray recently launched a new American-style light beer, Pub Light, as part of its beverage portfolio expansion [4]. - The company has acquired BrewDog Brewing Australia Pty Ltd., including its Brisbane brewery and several BrewDog bar locations [4]. Group 4: Technical Analysis - The stock is trading 5.2% below its 20-day simple moving average (SMA) and 12.9% below its 50-day SMA, indicating a bearish trend [5]. - Over the past 12 months, shares have increased by 11.79%, with a neutral RSI of 40.00 and a MACD suggesting a potential bullish crossover [5][6]. Group 5: Earnings and Analyst Outlook - Tilray is expected to provide its next financial update on April 7, 2026 [8]. - The EPS estimate is a loss of 1 cent, with a revenue estimate of $203.15 million, up from $185.78 million [10]. - The stock carries a Hold Rating, with recent analyst moves including a neutral rating from Roth Capital and a lowered target to $10.00 [11]. Group 6: ETF Exposure - Tilray has significant weight in the Amplify Alternative Harvest ETF (NYSE:MJ) at 12.38%, indicating that ETF inflows or outflows could impact the stock [12].
Tilray Medical, CC Pharma, and 14U Pharma Announce Strategic Alliance with “gesund leben” Cooperation and Alliance Healthcare Deutschland to Accelerate Market Expansion and Strengthen Pharmacy Access Across Germany
Globenewswire· 2026-03-12 11:00
Core Insights - Tilray Pharma has formed a strategic partnership with Tilray Medical, CC Pharma, and "gesund leben" cooperation to enhance its market presence in Germany [1][2][4] - The partnership aims to provide a comprehensive range of healthcare solutions, including prescription medications and medical cannabis, to pharmacies across Germany [2][5] Group 1: Partnership Details - The collaboration will take effect on April 1, 2026, focusing on improving pharmacy access and product availability [2] - The "gesund leben" cooperation includes approximately 3,600 member pharmacies, offering benefits such as digital access and competitive purchasing terms [3][8] - This partnership allows CC Pharma to access over 20% of German pharmacies, significantly expanding its market reach [4] Group 2: Market Context - Germany is identified as a crucial and dynamic healthcare market in Europe, making this partnership strategically significant for Tilray [4] - The alliance is expected to enhance service offerings and operational efficiency for pharmacies, thereby increasing customer traffic and sales [3][8] Group 3: Company Background - CC Pharma is a leading pharmaceutical distributor in Germany, serving over 16,000 pharmacies with a wide range of medicines [4][9] - Tilray Medical specializes in providing medical cannabis and has established itself as a significant supplier in the European market [10]
Lighter. Cheaper. Funner. Pub Light Is Here.
Globenewswire· 2026-03-11 11:00
Core Viewpoint - Pub Beer, a brand under Tilray Brands, Inc., has launched a new product called Pub Light, which is a 99-calorie American-style light lager with 4% ABV, aimed at providing a lighter and more affordable beer option for consumers [1][4]. Product Details - Pub Light is brewed with 100% malt and does not contain sugar, corn, rice, or filler ingredients, making it a clean and crisp lager [3]. - The beer is designed for easy drinking and social occasions, aligning with the brand's "Cheap Fun" philosophy [3][7]. - It is available in 16oz six-packs and 12oz eighteen-packs [5]. Brand Philosophy - The "Cheap Fun" brand ethos emphasizes straightforward, enjoyable beer without complex tasting notes or extravagant packaging, focusing instead on the experience of good times [7]. - The product aims to appeal to consumers looking for a no-nonsense beer option that is both approachable and enjoyable [3][4]. Company Background - Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company with a diverse portfolio that includes cannabis, beverages, wellness, and entertainment products [7]. - The company operates in multiple regions, including Canada, the United States, Europe, Australia, and Latin America, and aims to create memorable experiences through its brands [7].
Canadian Cannabis Stocks to Watch in March 2026 as Global Legalization Expands
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2026-03-10 14:00
Industry Overview - The global cannabis industry is evolving with ongoing legalization across various regions, and Canadian cannabis producers play a significant role in this expansion [1][2] - Canada was the first major developed country to legalize recreational cannabis, leading to the establishment of early industry leaders with large cultivation facilities and recognizable brands [2] - Post-legalization, the Canadian cannabis market has faced challenges such as oversupply, price compression, and heavy regulations, prompting many companies to restructure operations [2] Market Dynamics - The industry is shifting towards efficiency and profitability, with companies focusing on cost reduction and margin improvement [3] - International medical cannabis markets, particularly in Europe, are becoming increasingly important, with countries like Germany expanding their medical cannabis programs [3] - The United States remains the largest potential cannabis market, and Canadian companies are preparing strategies for potential entry as federal reform discussions continue [4] Company Strategies - Diversification has become a key strategy for cannabis companies, with expansions into beverages, wellness products, and pharmaceutical research to generate additional revenue streams [5] - Canadian cannabis stocks are characterized by high volatility but still present significant upside potential for investors [5] Key Companies to Watch Tilray Brands Inc. - Tilray is one of the largest global cannabis companies, producing medical and recreational products and operating across cannabis, beverages, and wellness markets [6][10] - The company reported quarterly revenue exceeding $217 million in fiscal 2026, showing modest growth and improved operational efficiency [11] - Tilray's international sales, particularly in Europe, are growing, and the company is positioning itself for potential U.S. legalization through acquisitions and brand development [12][10] Canopy Growth Corporation - Canopy Growth is a major player in the cannabis industry, producing a wide range of products and maintaining strong brand recognition [13][14] - The company reported quarterly cannabis revenue of nearly $52 million, reflecting moderate year-over-year growth, while also focusing on restructuring to improve profitability [18] - Canopy has established a structure for potential U.S. market entry and holds interests in several American cannabis operators [16][17] Cronos Group Inc. - Cronos Group focuses on research and product innovation, emphasizing premium cannabis brands and cannabinoid development [20][24] - The company reported quarterly revenue of approximately $44.5 million, driven by higher sales of cannabis flower and international distribution [25] - Cronos benefits from significant financial backing from Altria, allowing for continued investment in research and development [24][26]
Tilray's Going To Be Great, But For Now It's A Hold
Seeking Alpha· 2026-03-09 17:20
Core Insights - Systems Capital is a newly established holdings company focused on research and investment in high-quality systems, emphasizing the importance of strong business systems for long-term competitive advantages and performance [2] Group 1: Company Overview - Systems Capital operates with a single employee but is supported by a broader intellectual network that includes individuals from higher education, respected investors, and PhD-level researchers [2] - The firm prioritizes deep analysis and disciplined investment thinking over marketing or social media presence, focusing solely on investment performance and long-term value [2] Group 2: Founder Background - The founder of Systems Capital has over 10 years of investment experience, holding various roles in the investment industry, and is pursuing further qualifications such as the Chartered Financial Analyst (CFA) designation [2]
Tilray Brands Expects to Generate $1.2 Billion in Revenue Next Year, and It's Not the Way Investors Might Have Expected
Yahoo Finance· 2026-03-09 15:20
Group 1 - Tilray Brands is focused on growth and has diversified its operations significantly over the years [1][2] - The company projects to achieve a record $1.2 billion in annualized revenue by fiscal 2027, marking a substantial milestone [2][7] - Tilray's beverage operations are crucial for its growth, with recent acquisitions of craft brewers, including BrewDog, enhancing its market presence [5][6] Group 2 - The beverage segment generated $106 million in revenue for the six-month period ending November 30, 2025, indicating strong growth potential [8] - Despite the growth, much of it has been driven by acquisitions rather than organic growth, raising questions about the sustainability of this growth model [9]